Medical AI startup MEDICOLAB selected for and awarded an AMED project with a subsidy cap of about 109 million yen
Summary
MEDICOLAB received selection and grant approval for an AMED program with a subsidy cap of about 109 million yen. The company will use the funding to advance a medical AI program that estimates nuclear medicine-related evaluation information from head MRI images. It will validate the model across multiple medical institutions, prepare regulatory and quality management systems, and work toward domestic approval. MEDICOLAB also plans overseas validation and expansion, including preparation for the U.S. market.
Funding
Amount
-
Total raised
Date
July 31, 2026
Announcement date
Investors
-
Lead investors
Company
medicolab.co.jp
Funded company
AskAI Classifications
Sectors
HealthTech
Medical Management
General Healthcare software
Functions
No functions detected
Linked Companies
株式会社MEDICOLAB (Medicolab)
up to $1M